Bestion E

References (5)

Title : GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition - Bestion_2022_Viruses_14_132
Author(s) : Bestion E , Zandi K , Belouzard S , Andreani J , Lepidi H , Novello M , Rouquairol C , Baudoin JP , Rachid M , La Scola B , Mege JL , Dubuisson J , Schinazi RF , Mezouar S , Halfon P
Ref : Viruses , 14 :132 , 2022
Abstract :
PubMedSearch : Bestion_2022_Viruses_14_132
PubMedID: 35062337

Title : GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions - Brun_2022_Autophagy_18_678
Author(s) : Brun S , Bestion E , Raymond E , Bassissi F , Jilkova ZM , Mezouar S , Rachid M , Novello M , Tracz J , Hama A , Lalmanach G , Vanderlynden L , Legouffe R , Stauber J , Schubert T , Plach MG , Courcambeck J , Drouot C , Jacquemot G , Serdjebi C , Roth G , Baudoin JP , Ansaldi C , Decaens T , Halfon P
Ref : Autophagy , 18 :678 , 2022
Abstract :
PubMedSearch : Brun_2022_Autophagy_18_678
PubMedID: 34740311
Gene_locus related to this paper: human-PPT1

Title : GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer - Brun_2021_J.Cancer_12_5432
Author(s) : Brun S , Pascussi JM , Gifu EP , Bestion E , Macek-Jilkova Z , Wang G , Bassissi F , Mezouar S , Courcambeck J , Merle P , Decaens T , Pannequin J , Halfon P , Caron de Fromentel C
Ref : J Cancer , 12 :5432 , 2021
Abstract :
PubMedSearch : Brun_2021_J.Cancer_12_5432
PubMedID: 34405006

Title : GNS561 exhibits potent in vitro antiviral activity against SARS-CoV-2 through autophagy inhibition - Halfon_2020_bioRxiv__
Author(s) : Halfon P , Bestion E , Zandi K , Andreani J , Baudoin JP , La Scola B , Mege JL , Mezouar S , Schinazi RF
Ref : Biorxiv , : , 2020
Abstract :
PubMedSearch : Halfon_2020_bioRxiv__
PubMedID: 33052342

Title : GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-beta1 inhibition - Bestion_2020_Ther.Adv.Chronic.Dis_11_2040622320942042
Author(s) : Bestion E , Jilkova ZM , Mege JL , Novello M , Kurma K , Pour STA , Lalmanach G , Vanderlynden L , Fizanne L , Bassissi F , Rachid M , Tracz J , Boursier J , Courcambeck J , Serdjebi C , Ansaldi C , Decaens T , Halfon P , Brun S
Ref : Ther Adv Chronic Dis , 11 :2040622320942042 , 2020
Abstract :
PubMedSearch : Bestion_2020_Ther.Adv.Chronic.Dis_11_2040622320942042
PubMedID: 32728410